OTT & PI will be present as part of the French delegation to the BIO 2014 convention business which runs from June 23 to 26, 2014 in San Diego . BIO convention is a major convention for innovation actors in the field of health and medicine. This convention, organized by the Biotechnology Industry Organization (BIO) is held each year […]
Catégorie | English Flux RSS pour cette catégorie
Highest rating for clinical benefit from the French health authorities to Orphacol®, a treatment of rare liver diseases. Successful Transfer from AP-HP to Laboratoires CTRS
05/03/2014
Highest rating for clinical benefit from the French health authorities to Orphacol®,a treatment of rare liver diseases. Successful Transfer from AP-HP to Laboratoires CTRS The pharmaceutical company, Laboratoires CTRS, received the highest rating for improvement in medical benefit (Amélioration du Service Médical Rendu, ASMR 1[1]) from the French National Authority for Health’s Transparency Commission for […]
Last publications AP-HP’s teams and co-authors 2014-01-14
14/01/2014
Recommandations de la Société française de rhumatologie (SFR) pour la prise en charge en pratique courante des malades atteints de spondyloarthrite D Wendling, C Lukas, J Paccou, P Claudepierre… – Revue du Rhumatisme, 2014 … Amiens, 80000 Amiens, France; d Service de rhumatologie, laboratoire d’investigation clinique (LIC) EA4393, université Paris-Est-Créteil, hôpital Henri-Mondor, AP–HP, 94010 Créteil, […]
Newsletter Décembre 2013
13/12/2013
L’année 2013 touche à sa fin, ce fut une année riche en partenariats et innovations! 2013 is coming to end, it was a year of partnerships and innovations! Toute l’équipe de l’OTT&PI vous souhaite de bonnes fêtes de fin d’année et vous adresses ses meilleurs vœux pour 2014 ! OTT & PI team wishes you happy […]
Successful partnership between the AP- HP and CTRS laboratory: launching Orphacol ®, an orphan drug for « ultra rare » liver diseases
21/11/2013
Successful partnership between the AP- HP and CTRS laboratory: launching Orphacol ®, an orphan drug for « ultra rare » liver diseases To promote and market the fruit of research in the field of hereditary deficiency of bile acid synthesis by Professor E. Jacquemin (Service Pediatric Hepatology and Liver Transplantation , Bicetre Hospital , AP- HP ) […]
Biocitech, AP-HP cooperation agreement
06/07/2012
Biocitech, the Paris life sciences technology park, and AP-HP, the organization that includes 37 Paris hospitals, announced that they have signed a cooperation agreement. The agreement was signed at the ninth annual APinnov technology transfer conference in Paris, by Mireille Faugere, CEO of AP-HP and Jean-Francois Boussard, Biocitech president. Together, the two partners intend to […]
